XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Global Payments Shareholders’ Equity
Total Global Payments Shareholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Number of Shares
Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2019         300,226          
Balance at beginning of period at Dec. 31, 2019 $ 28,054,989 $ (5,379) $ 27,855,747 $ (5,379)   $ 25,833,307 $ 2,333,011 $ (5,379) $ (310,571) $ 199,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 605,100   584,520       584,520     20,580
Other comprehensive income (loss) 134,996   120,353           120,353 14,643
Stock issued under share-based compensation plans (shares)         1,726          
Stock issued under share-based compensation plans 66,142   66,142     66,142        
Common stock repurchased - share-based compensation plans (shares)         (316)          
Common stock repurchased - share-based compensation plans (60,849)   (60,849)     (60,849)        
Share-based compensation expense 148,792   148,792     148,792        
Noncontrolling interest of acquired business 14,812                 14,812
Purchase of subsidiary shares from noncontrolling interest (578,196)   (509,792)     (497,737)     (12,055) (68,404)
Distributions to noncontrolling interests $ (26,199)                 (26,199)
Repurchase of common stock (shares) (3,304)       (3,304)          
Repurchases of common stock $ (633,948)   (633,948)     (525,886) (108,062)      
Cash dividends declared (233,216)   (233,216)       (233,216)      
Balance at end of period (shares) at Dec. 31, 2020         298,332          
Balance at end of period at Dec. 31, 2020 27,487,044   27,332,370     24,963,769 2,570,874   (202,273) 154,674
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 987,864   965,460       965,460     22,404
Other comprehensive income (loss) (42,282)   (32,001)           (32,001) (10,281)
Stock issued under share-based compensation plans (shares)         2,085          
Stock issued under share-based compensation plans 49,545   49,545     49,545        
Common stock repurchased - share-based compensation plans (shares)         (498)          
Common stock repurchased - share-based compensation plans (90,165)   (90,165)     (90,165)        
Share-based compensation expense 180,779   180,779     180,779        
Contributions from noncontrolling interests 69,987                 69,987
Change in ownership attributable to a noncontrolling interest $ 0   (4,432)     (4,524)     92 4,432
Repurchase of common stock (shares) (15,169)       (15,169)          
Repurchases of common stock $ (2,513,629)   (2,513,629)     (2,219,143) (294,486)      
Cash dividends declared (259,726)   (259,726)       (259,726)      
Balance at end of period (shares) at Dec. 31, 2021         284,750          
Balance at end of period at Dec. 31, 2021 25,869,417   25,628,201     22,880,261 2,982,122   (234,182) 241,216
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 143,313   111,493       111,493     31,820
Other comprehensive income (loss) (185,088)   (171,787)           (171,787) (13,301)
Stock issued under share-based compensation plans (shares)         1,883          
Stock issued under share-based compensation plans 44,127   44,127     44,127        
Common stock repurchased - share-based compensation plans (shares)         (285)          
Common stock repurchased - share-based compensation plans (38,423)   (38,423)     (38,423)        
Share-based compensation expense 163,261   163,261     163,261        
Distributions to noncontrolling interests (23,031)                 (23,031)
Purchase of capped calls related to issuance of convertible notes, net of taxes of $72,778 $ (229,597)   (229,597)     (229,597)        
Repurchase of common stock (shares) (23,266)       (23,266)          
Repurchases of common stock $ (2,929,814)   (2,929,814)     (2,841,534) (88,280)      
Cash dividends declared (273,955)   (273,955)       (273,955)      
Balance at end of period (shares) at Dec. 31, 2022         263,082          
Balance at end of period at Dec. 31, 2022 $ 22,540,210   $ 22,303,506     $ 19,978,095 $ 2,731,380   $ (405,969) $ 236,704